Ardsley Advisory Partners’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,500
Closed -$83K 150
2018
Q3
$83K Buy
+1,500
New +$83K 0.01% 130